Literature DB >> 30125533

Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior.

Jessica R Barson1.   

Abstract

At its discovery, orexin/hypocretin (OX) was hypothesized to promote food intake. Subsequently, with the identification of the participation of OX in numerous other phenomena, including arousal and drug seeking, this neuropeptide was proposed to be involved in highly motivated behaviors. The present review develops the hypothesis that the primary evolutionary function of OX is to promote foraging behavior, seeking for food under conditions of limited availability. Thus, it will first describe published literature on OX and homeostatic food intake, which shows that OX neurons are activated by conditions of food deprivation and in turn stimulate food intake. Next, it will present literature on excessive and binge-like food intake, which demonstrates that OX stimulates both intake and willingness to work for palatable food. Importantly, studies show that binge-like eating can be inhibited by OX antagonists at doses far lower than those required to suppress homeostatic intake (3 mg/kg vs. 30 mg/kg), suggesting that an OX-based pharmacotherapy, at the right dose, could specifically control dysregulated eating. Finally, the review will discuss the role of OX in foraging behavior, citing literature which shows that OX neurons, which are activated during the anticipation of food reward, can promote a number of phenomena involved in successful foraging, including food-anticipatory locomotor behavior, olfactory sensitivity, visual attention, spatial memory, and mastication. Thus, OX may promote homeostatic eating, as well as binge eating of palatable food, due to its ability to stimulate and coordinate the activities involved in foraging behavior.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Binge; Fat; Palatable; Reinstatement; Seeking; Sucrose

Mesh:

Substances:

Year:  2018        PMID: 30125533      PMCID: PMC6378128          DOI: 10.1016/j.brainres.2018.08.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  133 in total

1.  Orexin B immunoreactive fibers and terminals innervate the sensory and motor neurons of jaw-elevator muscles in the rat.

Authors:  Jingdong Zhang; Pifu Luo
Journal:  Synapse       Date:  2002-05       Impact factor: 2.562

2.  Hypothalamic hypocretin/orexin and neuropeptide Y: divergent interaction with energy depletion and leptin.

Authors:  B Beck; S Richy
Journal:  Biochem Biophys Res Commun       Date:  1999-04-29       Impact factor: 3.575

Review 3.  Orexin receptors: pharmacology and therapeutic opportunities.

Authors:  Thomas E Scammell; Christopher J Winrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

4.  Presynaptic Regulation of Leptin in a Defined Lateral Hypothalamus-Ventral Tegmental Area Neurocircuitry Depends on Energy State.

Authors:  Jing-Jing Liu; Nicholas T Bello; Zhiping P Pang
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

5.  Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity.

Authors:  Jeffrey J Olney; Montserrat Navarro; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

6.  Role of orexin/hypocretin in conditioned sucrose-seeking in rats.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2012-10-25       Impact factor: 4.530

7.  Role of orexin/hypocretin in conditioned sucrose-seeking in female rats.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2014-07-15       Impact factor: 5.250

8.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

Review 9.  Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system.

Authors:  Natsuko Tsujino; Takeshi Sakurai
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

10.  Effect of Orexin A antagonist (SB-334867) infusion into the nucleus accumbens on consummatory behavior and alcohol preference in Wistar rats.

Authors:  Santosh Mayannavar; K S Rashmi; Yalla Durga Rao; Saraswati Yadav; B Ganaraja
Journal:  Indian J Pharmacol       Date:  2016 Jan-Feb       Impact factor: 1.200

View more
  13 in total

1.  Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?"

Authors:  Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2020-01-10       Impact factor: 3.252

2.  Hindbrain orexin 1 receptors blunt intake suppression by gastrointestinal nutrients and cholecystokinin in male rats.

Authors:  Diana L Williams; Isabel I Coiduras; Eric M Parise; Calyn B Maske
Journal:  Peptides       Date:  2020-06-21       Impact factor: 3.750

3.  The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.

Authors:  Joost Wiskerke; Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-04-16       Impact factor: 3.252

4.  Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine.

Authors:  Caroline B Pantazis; Morgan H James; Shayna O'Connor; Noah Shin; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2021-10-11       Impact factor: 7.853

5.  Hedonic Eating: Sex Differences and Characterization of Orexin Activation and Signaling.

Authors:  Laura Buczek; Jennifer Migliaccio; Gorica D Petrovich
Journal:  Neuroscience       Date:  2020-04-10       Impact factor: 3.590

Review 6.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

7.  Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.

Authors:  Aida Mohammadkhani; Morgan H James; Caroline B Pantazis; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-09-14       Impact factor: 3.252

Review 8.  Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.

Authors:  Jacqueline B Mehr; Deborah Mitchison; Hannah E Bowrey; Morgan H James
Journal:  Neuropsychopharmacology       Date:  2021-06-18       Impact factor: 7.853

Review 9.  The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics.

Authors:  Rebecca G Boswell; Marc N Potenza; Carlos M Grilo
Journal:  Clin Ther       Date:  2020-11-27       Impact factor: 3.393

10.  Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System.

Authors:  Linnea R Freeman; Brandon S Bentzley; Morgan H James; Gary Aston-Jones
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.